Jennison Associates LLC Arcturus Therapeutics Holdings Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$38.75 - $86.92 $858,041 - $1.92 Million	-22,143 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$34.61 - $123.66 $33,675 - $120,321	-973 Reduced 4.21%	22,143 $961,000
Q3 2020 Nov 04, 2020	SELL	$37.49 - $63.19 $5.19 Million - $8.74 Million	-138,308 Reduced 85.68%	23,116 $992,000
Q2 2020 Aug 06, 2020	BUY	$12.66 - $58.27 $2.04 Million - $9.41 Million	161,424 New	161,424 $7.55 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.